← Return to Anyone here after ADT undergone TRT

Discussion
ava11 avatar

Anyone here after ADT undergone TRT

Prostate Cancer | Last Active: Aug 13 6:16pm | Replies (21)

Comment receiving replies
Profile picture for sahallock1947 @sahallock1947

I had eligard for a year with zeros for PSA and T levels we paused the eligard and for a year afterwards everything thing was still zeros and I was still anemic. After lots of discussion we started TRT but my testosterone levels were near 1000 at the start. Over a year I reduced the T amount I was taking until I was no more than 5% of what we started with. At this level my T blood levels were < 100 and still no PSA but good hemoglobin levels. My PSA began to wiggle a bit above zero, so we started ADT again. The whole time period of this was about 4 years. It was nice while it lasted. My T levels dropped back to zero, and I became anemic again and I got the pleasure of experiencing hot flashes once again. I’m now 10 years past initial diagnosis, and have just gone off eligard, but am continuing xtandi treatments of 2 pills per day. The xtandi started 2 years ago. I think there are better options than eligard, especially for long term use. There’s some debate between my urologist and I, but I think the eligard was a major factor in the decline of my kidney function, which I’m now battling along with everything else.

Jump to this post


Replies to "I had eligard for a year with zeros for PSA and T levels we paused the..."

You've had quite an experience during the last ten years.

Since you're been doing this for so long and have enjoyed testosterone in the past, I'm wondering whether you've given any consideration to trying the bi-polar androgen therapy (BAT) treatment?

Dr. Sam Denmeade, a John Hopkins medical oncologist, has been the BAT pioneer. I've watched several videos where he talks about the BAT method which also delivers a higher quality of life than most (perhaps all) other types of prostate cancer treatments. More importantly, Dr. Denmeade specifically asserts he's willing to consult with other patient's oncologists on how to administer BAT.